UB-RASDisease
The UB-RASDisease project is being carried out at The Flanders Institute for Biotechnology (VIB). Having been awarded an ERC consolidator grant, lasting approximately 5 years, it will look to find ways to defeat RAS-driven disease. By creating genetically modified mouse models and CRISPR-engineered human cell models they can assess the functional impact of the alterations…










